Association of induced atrial fibrillation in the electrophysiology laboratory with endothelial dysfunction and documented atrial fibrillation
Künye
Durak, H., & Ergül, E. (2024). Association of induced atrial fibrillation in the electrophysiology laboratory with endothelial dysfunction and documented atrial fibrillation. International Journal of Cardiology, 415, 132465. https://doi.org/10.1016/j.ijcard.2024.132465Özet
Objective: Atrial fibrillation (AF) is a common arrhythmia that increases morbidity and mortality, as well as healthcare costs. The induction of AF (IAF) during programmed atrial pacing in an electrophysiological study (EPS) is a prevalent phenomenon that has been underappreciated by electrophysiologists. Despite extensive research on AF, only a few studies have focused on this phenomenon. The aim of our study was to investigate the association between history of AF and IAF and the underlying pathophysiological factors such as arterial stiffness, subclinical atherosclerosis, and impaired endothelial function. Methods: This cross-sectional and observational study included 87 patients who had palpitations and were scheduled for EPS. Patients underwent biochemical investigations, transthoracic echocardiography, carotid ultrasound, carotid-femoral artery pulse wave velocity (PWV), and flow-mediated dilatation (FMD) measurements before EPS. Patients were divided into two groups, AF-induced and non-induced in EPS, for further statistical analysis. Results: AF was induced in 16 of 87 patients (18.3%) included in the analysis. The FMD (%) was significantly lower (16.01 ± 10.1 vs. 8.7 ± 5.7, P = 0.022) and, remarkably, the proportion of patients with a history of AF was significantly higher (2.8% vs. 37.5%, P < 0.001) in the IAF group. ROC analysis showed that a documented AF and FMD predicted IAF, with AUC of 0.741 (p = 0.012) and 0.740 (p = 0.001), respectively. Logistic regression analysis revealed that FMD and history of AF were strong predictors of IAF (odds ratio [OR], 0.853; 95% confidence interval [CI] 0.737–0.988; P = 0.034, OR: 10.1, 95% CI 4.9–20.5; P = 0.003, respectively). Conclusion: Endothelial dysfunction and documented AF were associated with IAF during EPS.
Kaynak
International Journal of CardiologyCilt
415Koleksiyonlar
İlgili Öğeler
Başlık, yazar, küratör ve konuya göre gösterilen ilgili öğeler.
-
Turkish real ife atrial fibrillation in clinical practice: TRAFFIC study
Karabay, Can Yücel; Taşolar, Hakan; Kunak, Ayşegül Ülgen; Çap, Murat; Astarcıoğlu, Mehmet Ali; Şen, Taner; Kaplan, Mehmet; Coşgun, Muharrem Said; Ağca, Fahriye Vatansever; Arslan, Uğur; Açıksarı, Gönül; Er, Fahri; Mert, Kadir Uğur; Özdoğan, Öner; Çalışkan, Serhat; Akşit, Ercan; Yılmaz, Ahmet Seyda; Aksakal, Emrah; Şimşek, Zeki; Efe, Süleyman Çağan; Aktüre, Gülşah; Böyük, Ferit; Başaran, Özcan; Ballı, Mehmet; Aslan, Ahmet Oğuz; Güler, Gamze Babur; Batgerel, Ulaankhuu; Özkalaycı, Flora; Kaya, Bedri Caner; Kanar, Batur Gönenç; Karakayalı, Muammer; Erdoğan, Emrah; İş, Gürkan; Kalkan, Sedat; Demirel, Sinan; Aksu, Uğur; Güray, Ümit; Baş, Hasan Aydın; Gök, Murat; Yılmaz, Mehmet Fatih; Şimşek, Barış; Kolak, Zeynep; Öz, Melih; Uluköksal, Utku; Kuloğlu, Hüseyin Emre; Çabuk, Gizem; Köksal, Fatma; Nizam, Ahmet Cem; Çoldur, Rabia; Şaylık, Faysal; Tanboğa, İbrahim Halil (Turkish Society of Cardiology, 2024)Background: Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia worldwide and is associated with an increased risk of thromboembolism, ischemic stroke, impaired quality of life, and mortality. The latest ... -
Serum osteoprotegerin level is independently related to subclinical left atrial mechanical function in patients with hypertension and diabetes
Kalaycıoğlu, Ezgi; Çetin, Mustafa; Çinier, Göksel; Kırış, Tuncay; Gökdeniz, Tayyar; Özyıldız, Ali Gökhan; Durmus, Ismet (Urban & Vogel, 2020)Objectives Previous studies showed that subclinical abnormal left atrial (LA) function could be diagnosed with LA speckle tracking evaluation long before chamber enlargement. Osteoprotegerin (OPG) is a member of the tumor ... -
Assessment of treatment patterns and patient awareness in atrial fibrillation patients using non-vitamin K antagonist oral anticoagulants (ASPECT-NOAC)
Badak, Özer; Demir, Ali Rıza; Önal, Tugay; Akgün, Taylan; Yontar, Osman Can; Şatıroğlu, Ömer; Duman, Hakan; Okuyan, Ertuğrul; Melek, Mehmet; Dural, İbrahim Etem (Elsevier, 2022)Background and Aim: Despite the advances in oral anticoagulation with NOACs, careful patient and dose selection is required with NOAC therapy. Our study aimed to assess treatment patterns of NOACs in AF along with patients' ...